close
MENU
General Business
2 mins to read

Comcom approves Pfizer GSK merger

One step in a long road for pharma giants' merger.

The Commerce Commission has approved GlaxoSmithKline's (GSK) acquisition of the consumer healthcare business of Pfizer Inc.

Consumer healthcare products are medicines and treatments that can be bought without a prescription.

Commission chair Mark Berry said the commission was satisfied that

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Sanjay Prakash Tue, 30 Apr 2019
Contact the Writer: Sanjay@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Comcom approves Pfizer GSK merger
General Business,
79058
true